(Total Views: 71)
Posted On: 12/09/2024 11:03:03 AM
Post# of 38429
$PHRRF recent News : PharmaTher Announces Update on FDA New Drug Application for Ketamine
FDA provided preliminary responses to questions contained in the clarification only post-CRL meeting scheduled for December 2, 2024
PharmaTher has decided to cancel the meeting as the FDA preliminary responses were satisfactory and do not require further discussion
PharmaTher initiated activities to address the MINOR deficiencies cited in the CRL
https://finance.yahoo.com/news/pharmather-ann...00255.html
FDA provided preliminary responses to questions contained in the clarification only post-CRL meeting scheduled for December 2, 2024
PharmaTher has decided to cancel the meeting as the FDA preliminary responses were satisfactory and do not require further discussion
PharmaTher initiated activities to address the MINOR deficiencies cited in the CRL
https://finance.yahoo.com/news/pharmather-ann...00255.html
(0)
(0)
